Brief: Collegium Pharmaceutical Q2 Revenue USD 145.3 Million Vs. IBES Estimate USD 143.9 Million
08/08/2024 21:01
Aug 08 (Reuters) - Collegium Pharmaceutical Q2 net income USD 19.6 million. * Q2 adjusted EBITDA USD 96 million vs. IBES estimate USD 94.1 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%